5-aminosalicylic acid (5-ASA)
DISEASE INTERVENTION COMPARISON RESULTS
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000544 Systematic Review, Cochrane Review
IN inflammatory bowel disease, ulcerative colitis The Use of
5-aminosalicylic acid (5-ASA)
As Treatment, Chronic
Is worse Than
sulfasalazine
To to maintain clinical or endoscopic remission: OR 1.29 (95%CI, 1.05 to 1.57), NNT negative (-19) for the comparison 5-ASA versus salazopirine